Business Wire

TELSTRA

3.3.2021 10:02:11 CET | Business Wire | Press release

Share
Telstra Research unveiled: Business survival in a post-COVID world

Telstra, a leading Australian telecommunications and technology company, has today published a report in partnership with Vanson Bourne, that reveals the impact of COVID-19 on European businesses, and how some are using digital transformation to pivot business models to adapt to a post-COVID world.

The research, based on interviews with 500 senior IT and business decision makers in private sector organisations across Europe, explores how organisations are pursuing their digital transformation and innovation initiatives, the need for agility and the challenges of cybersecurity in the wake of COVID-19.

Security – an ever-evolving and challenging landscape

Cybersecurity is more important now than ever before. The COVID-19 pandemic presented cybercriminals with increased opportunities to breach the defences of organisations, making improvements increasingly important for European companies and their workforces. The research revealed that over half (65%) of respondents saw a dramatic rise in cyberattacks on their organisation during the pandemic.

In addition to hacking efforts, businesses reported increased pressure from phishing (44%), fake contact tracing apps and calls (43%) and ransomware (43%), with the greatest increase in incidents in the energy, oil, gas and utilities sector (80%).

Fifty-six percent cited improving cybersecurity as among the top priorities within their recovery strategy, ahead of increasing the pace of digital transformation projects (51%) and increasing investment in emerging technologies (50%), all of which can sharpen organisations’ competitive edge as they emerge from the pandemic.

Digital Transformation in a COVID world

Showing great resilience to the difficult circumstances wrought by the pandemic, the businesses surveyed reported strong progression of their digital transformation and innovation plans. Sixty-five percent of respondents say most or all of their organisation’s digital transformation and innovation projects are currently active, with only 28% claiming to have fully executed their digital transformation.

However, many decision makers still believe more could be done, with 83% agreeing their organisation needs to increase the pace of its digital transformation, which is unanimous across all the regions and verticals surveyed. European businesses have made vigorous investments in digital transformation despite the financial downturn, with respondents spending over $2.28 million (USD) on projects since the start of 2020. This is an average increase of 2.71% as a result of the pandemic.

Of those surveyed, the financial services industry reported 3.5 times more digital investment than any other sector with a spend of $6.55 million (USD). Artificial intelligence (AI) is cited as the key technology being prioritised (41%), a likely result of businesses attempting to better understand their customers. Other technologies being prioritised include 5G (35%), Internet of Things (34%) and edge computing (30%), all of which are geared towards enhancing network performance, connectivity and security. Interestingly, respondents from the UK and Ireland were the most likely to report that their organisation is prioritising investment in AI (53%), the Internet of Things (48%) and 5G (37%).

Meanwhile, most businesses recognised the need to include their supply chain in digital transformation projects, with 89% of respondents agreeing that involvement could lead to improved success levels for their organisation. Around a quarter (24%) reported their organisation has fully adapted to the changes arising from the pandemic, with a similar proportion (26%) saying the same for their supply chain. Encouragingly, 79% believe that the agility of their organisation, including its supply chain, has increased as a result of the pandemic.

Agility – a business necessity

The research showed that business agility became vital during the pandemic, with success hinging on how quickly organisations could react and adapt to a disparate workforce and customer base. Those who adapted quickly were the winners and many cited cloud as the key technology that enabled their success.

Surprisingly only 23% of respondents reported their organisation has a cloud-first strategy, with almost half (49%) expressing a need to migrate more applications to the cloud. Ultimately, the research showed that whether organisations implemented a cloud-only or hybrid model, they cannot afford to forego the agility benefits that cloud can deliver for both network and business performance.

Flexible working has become a business necessity, with 40% saying flexible working is the top enabler for business agility. While the majority indicated uptake of networking tools that enable flexible working, 71% indicated that they see room for improvement with their organisation’s network – some of the key areas that could improve were agility to scale bandwidth up and down to meet demand (36%), automation and use of software defined network technology (35%), and optimization of application performance (30%).

Matt Williams, Head of Telstra, EMEA said:

“From our research, it’s heartening to note that organisations are moving in the right direction with their digital transformation strategies, with the majority identifying themselves as more agile than they were before. However, agility is not the only factor in a business’ ability to survive through the pandemic. Digital supply chains and protecting yourself from cyberattacks are mission critical. When these three elements are fully addressed – with cybersecurity underpinning the agenda – organisations will be able to emerge into the post-pandemic world with confidence.”

The full report can be downloaded here .

ENDS

About Telstra:

Telstra is a leading telecommunications and technology company with a proudly Australian heritage and a longstanding, growing international business.

Today, we operate in over 20 countries outside of Australia, providing services to thousands of business, government, carrier and OTT customers. Telstra Enterprise is a division of Telstra that provides data and IP networks and network application services, such as managed networks, unified communications, cloud, industry solutions and integrated services. Telstra Purple, our new professional and managed services business in Australia, Asia and the UK, brings together people and innovative solutions to define and deliver a clear vision of our customers’ transformation journey, network foundation, and the protection they need to thrive.

Telstra’s global network includes more than 26 cable systems spanning over 400,000 kilometres, with access to multiple cable landing stations and more than 2,000 points of presence around the world. Our subsea cable network is the largest in Asia Pacific, with access to the most lit capacity not just in Asia, but also from the region to Australia, USA and Europe.

For more information, visit telstra.co.uk

About Vanson Bourne:

Vanson Bourne is an independent specialist in market research for the technology sector. Their reputation for robust and credible research-based analysis is founded upon rigorous research principles and their ability to seek the opinions of senior decision makers across technical and business functions, in all business sectors and all major markets. For more information, visit www.vansonbourne.com

Research scope and methodology:

Telstra commissioned independent market research specialist Vanson Bourne to undertake the research for this white paper. A total of 500 senior IT and business decision makers, including C-suite employees, were interviewed during September and October 2020, with representation around Europe (UK & Ireland, France, Germany, Nordics (Sweden & Denmark) and Netherlands).

Respondents had to be from organisations with at least 1,000 employees and came from a range of private sectors.

The interviews were conducted online and were undertaken using a rigorous multi-level screening process to ensure that only suitable candidates were given the opportunity to participate. Unless otherwise indicated, the results discussed are based on the total sample.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye